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ABSTRACT
Background: Pendrin and periostin are newly identified mediators of the inflammatory process. The expres-
sion of these proteins in human sinonasal tissue and their roles in allergic rhinitis and chronic rhinosinusitis re-
main to be elucidated. This study investigated the expression of pendrin and periostin in sinonasal tissue of pa-
tients with allergic rhinitis, chronic rhinosinusitis, and aspirin-induced asthma. Prospective control study con-
ducted at Yamagata University, Japan.
Methods: Surgical samples were investigated by means of real-time reverse transcription-polymerase chain
reaction to evaluate the expression of pendrin and periostin mRNA. The presence and location of pendrin and
periostin were determined by immunohistochemistry and Western blotting.
Results: Pendrin and periostin production was significantly higher in patients with nasal disorders than in con-
trols. Further significant increases in periostin expression were noted in patients with chronic rhinosinusitis with
nasal polyps and in those with aspirin-induced asthma. Immunohistochemistry revealed positive staining for
pendrin in epithelial cells and submucosal glands and for periostin in the basement membrane in all three disor-
ders, and additionally for periostin in nasal polyp tissue in chronic rhinosinusitis and aspirin-induced asthma.
Conclusions: Production of pendrin and periostin is upregulated in allergic rhinitis, chronic rhinosinusitis with
nasal polyps, and aspirin-induced asthma. These findings suggest that pendrin can induce mucus production
and that periostin can induce tissue fibrosis and remodeling in the nasal mucosa. Therefore, these mediators
may be therapeutic target candidates for allergic rhinitis, chronic rhinosinusitis with nasal polyps, and aspirin-
induced asthma.
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INTRODUCTION
The presenting symptoms of nasal disorders such as
allergic rhinitis, chronic rhinosinusitis with nasal pol-
yps, and aspirin-induced asthma include nasal dis-
charge and nasal congestion, which are responsible
for not only decreasing quality of life, but also imped-
ing the activities of daily living. These pathological
conditions, which lead to mucus overproduction and
edema in the nasal mucosa, might be precipitated by
the actions of molecules such as pendrin and pe-
riostin. Periostin is an extracellular matrix protein
originally isolated from an osteoblast cell line; its pro-
duction is induced by IL-4 and IL-13 in airway epithe-
lial cells.1-4 Periostin is also a regulator of fibrosis and
collagen deposition, and although it has been recog-
nized for its important role in myocardial repair and
remodeling following myocardial infarction,2 its over-
production in the nasal mucosa has been reported to
contribute to polyp formation.5 Although we know
that pendrin is genetically associated with Pendred
syndrome, pendrin has recently been found to induce
Allergology International. 2012;61:589-595
ORIGINAL ARTICLE
1Department of Otolaryngology, Head and Neck Surgery, Faculty
of Medicine, Yamagata University, Yamagata, 2Department of
Otolaryngology, Nippon Medical School, Tokyo, 3Department of
Otolaryngology, Japanese Red Cross Society, Wakayama Medical
Center, Wakayama and 4Division of Medical Biochemistry, Depart-
ment of Biomolecular Sciences, Faculty of Medicine, Saga Medical
School, Saga, Japan.
Conflict of interest: No potential conflict of interest was disclosed.
Correspondence: Nobuo Ohta, MD, Department of Otolaryngol-
ogy, Head and Neck Surgery, Yamagata University Faculty of
Medicine, 2−2−2 Iida-nishi, Yamagata 990−9585, Japan.
Email: noohta@med.id.yamagata−u.ac.jp
Received 9 September 2011. Accepted for publication 13 April
2012.
2012 Japanese Society of Allergology
DOI: 10.2332allergolint.11-OA-0370
Ishida A et al.
590 Allergology International Vol 61, No4, 2012 www.jsaweb.jp
Table　1　Patient data and immunohistochemistry, qRT-PCR, and Western blotting parameters
Assay No. Sex(male/female) Age CT stage No. of patients with asthma (%)
Immunohistochemistry
AR 10 5/5 51.2 (24-72) 0  1 ( 10%)
CRS 10 5/5 49.3 (28-69) 3.4 ± 0.5  3 ( 30%)
AIA 10 4/6 50.5 (26-74) 3.7 ± 0.5 10 (100%)
Control  7 3/4 43.6 (31-68) 0  0 (  0%)
Total 37 17/20
qRT-PCR
AR 10 5/5 51.2 (24-72) 0  1 ( 10%)
CRS 19  9/10 50.4 (28-74) 3.5 ± 0.6  6 ( 32%)
Control  7 3/4 43.6 (31-68) 0  0 (  0%)
Total 36 17/19
Western blotting
AR  6 3/3 52.1 (24-72) 0  0 (  0%)
CRS 14 7/7 51.1 (28-71) 3.3 ± 0.5  5 ( 36%)
Control  7 3/4 43.6 (31-68) 0  0 (  0%)
Total 27 13/14
AR, allergic rhinitis; CRS, chronic rhinosinusitis with nasal polyps; AIA, aspirin-induced asthma; qRT-PCR, quantitative reverse transcrip-
tion polymerase chain reaction; CT, computed tomography.
increased mucus production in airway epithelial cells,
suggesting its potential involvement in asthma-
induced airway inflammation and occlusion.6-12 How-
ever, current evidence for the relationship of pendrin
and periostin with various nasal disorders is scarce.
Therefore, we investigated the expression of pendrin
and periostin in nasal tissue from patients with aller-
gic rhinitis, chronic rhinosinusitis with nasal polyps,
and aspirin-induced asthma.
METHODS
SUBJECTS
This study was approved by the ethics committee of
the Yamagata University Faculty of Medicine and
conducted with informed consent from the patients.
Forty-six patients who underwent functional endo-
scopic sinus surgery, septal surgery, or inferior tur-
binectomy were enrolled for assessments involving
immunohistochemistry, quantitative real-time polym-
erase chain reaction (RT-PCR), and Western blotting
(Table 1). Patients were allocated to one of four
groups: allergic rhinitis, chronic rhinosinusitis with
nasal polyps, aspirin-induced asthma, or control. The
control group consisted of patients who were under-
going septoplasty because of anatomic variations and
who had no sinus disease; inferior turbinate mucosal
samples were taken from these patients during sur-
gery. Chronic rhinosinusitis with nasal polyps was di-
agnosed according to the clinical criteria of Meltzer et
al.9 on the basis of patient history, clinical examina-
tion, nasal endoscopy, and sinus computed tomogra-
phy. Diseased sinus mucosal tissue and nasal polyp
tissue were collected during surgery. Subjects were
excluded if they had received oral steroids or immu-
notherapy in the 3 months before surgery or if they
had undergone previous sinus surgery.
IMMUNOHISTOCHEMISTRY FOR DETECTING
PENDRIN AND PERIOSTIN
For immunohistochemical examination of periostin
we used the labeled streptavidin-biotin complex
method. Deparaffinized tissue sections were rehy-
drated in alcohol. The sections were then autoclaved
for 10 min at 120℃ in citrate phosphate buffer (pH
6.0) for antigen retrieval. Endogenous peroxidase ac-
tivity was blocked with 0.3% H2O2 for 30 min. The sec-
tions were then incubated with normal skim milk in
phosphate-buffered saline (PBS) for 10 min to block
nonspecific background staining. Polyclonal anti-
pendrin antibody and polyclonal anti-periostin anti-
body generated by immunizing rabbits with specific
peptides were kindly provided by Dr. Izuhara.3,6 Poly-
clonal antibody against pendrin (diluted 1 : 100) and
polyclonal antibody against periostin (diluted 1 : 500)
were applied as the respective primary antibodies,
and tissue sections were incubated overnight at 4℃.
The sequences of these peptides are available on re-
quest. After the sections had been washed with PBS,
biotinylated goat anti-rabbit IgG was applied, and the
sections were incubated for 1 h at room temperature.
Slides were developed with diaminobenzine and
counterstained with hematoxylin.
Positive staining for pendrin was quantitatively ana-
lyzed by design-based stereology.13 Measurements
were recorded by a blinded investigator using a ×20
objective lens. The volume density of immunostain-
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ing was calculated by quantification of the volume of
stained mucosal epithelium referenced to the surface
area of the surveyed basal lamina (cubic micrometers
per square micrometer).
ASSESSMENT OF SLIDES
Immunostained sections were assessed under an
Olympus microscope with a ×200 eyepiece reticle.
Cell counts were expressed as mean per high-power
field (0.202 mm2) values. At least two sections were
immunostained, and more than five areas were evalu-
ated via the graticule. Results are expressed as the
number of positive cells per field.
QUANTITATIVE PCR ANALYSIS OF PENDRIN
AND PERIOSTIN
Total RNA was isolated from nasal tissue using an
RNeasy Mini Kit with RNase-Free DNase Set
(Qiagen, Hilden, Germany). RNA was dissolved in
RNase-free water and stored at -80℃ according to the
manufacturer’s protocols. Preparations were quanti-
fied, and their purity was determined by standard
spectrophotometric methods. cDNA was produced in
a 20-μL reaction tube from 1 μg total RNA, 20 units of
AMV reverse transcriptase (Roche Diagnostics,
Mannheim, Germany), 1 × AMV reaction buffer, 10
nM deoxynucleotide triphosphates, and 3.2 μg ran-
dom hexamers. The reactions were incubated at 25℃
for 10 min, 42℃ for 1 h, and 94℃ for 5 min. Primer
sequence pairs were as follows: human pendrin, 5’-
TTG ACG GTC CAT GAT GCT A-3’ (forward) and 5’-
TTC AGG ATG CAA GTG TAC G-3’ (reverse) (prod-
uct size, 187 bp); human periostin, 5’-TTT GCT GGC
ACC TGT GAA TA-3’ (forward) and 5’-TTT GCC TCC
GAT GGT TTC-3’ (reverse) (product size, 154 bp). β-
actin was used as an internal control. Two β-actin
primer pairs (Light Cycler human β-actin primer set,
Roche Diagnostics) were also used.
Quantitative PCR analysis was performed using the
LightCycler instrument (Roche Diagnostics). Each
reaction contained 5 μL cDNA, 0.5 μM of each
primer, 1 × Detection Mix, and 1 × LightCycler Fast-
Start DNA Master SYBERGreen I in a 20-μL volume.
Each reaction capillary underwent 10 min incubation
at 95℃ before 45 cycles of 95℃ for 10 s, 60℃ for 10
s, and 72℃ for 8 s. Melting curve analysis in SYBER
Green I format after the end of the amplification cy-
cles was performed at 95℃ for 0 s, 70℃ for 15 s, and
95℃ for 0 s. PCR runs were concluded with incuba-
tion at 40℃ for 30 s. This melting curve analysis was
performed to verify the specificity of each primer.
Agarose-gel observations revealed that no non-
specific PCR products were amplified under these
conditions. All mRNA levels are expressed as the
number of copies per 1000 copies of β-actin.
WESTERN BLOTTING FOR PERIOSTIN
Antiperiostin serum was generated by purified His-
tagged or V5 epitopeHis-tagged periostin possessing
exons 17 to 21 in the C-terminal portion, together
with complete Freund adjuvant (Sigma Aldrich, St.
Louis, MO, USA) for immunization of New Zealand
White rabbits. Nasal tissue was lysed in PBS contain-
ing 1% SDS, and the tissue lysates were boiled with
SDS sample buffer containing 7 M urea. Samples
were applied to SDS-PAGE and electrophoretically
transferred to polyvinylidene difluoride membranes
(GE Healthcare Bio-Sciences, Piscataway, NY, USA).
The membranes were blotted with anti-periostin se-
rum and periostin was visualized on Hyperfilm ECL
(GE Healthcare Bio-Sciences).
STATISTICS
Control group means (arithmetic mean ± SD) were
compared with patient group means using the Mann-
Whitney U-test at P = 0.05.
RESULTS
PRODUCTION OF PENDRIN IN NASAL MUCOSA
Pendrin-positive staining was demonstrated in apical
membrane of epithelial cells by means of immunohis-
tochemical staining (Fig. 1A-D). Production of pen-
drin protein was significantly higher in tissues from
patients with allergic rhinitis (mean = 13.2), chronic
rhinosinusitis with nasal polyps (mean = 12.8), or
aspirin-induced asthma (mean = 12.8) than in control
tissues (mean = 3.7) (P < 0.05) (Fig. 1E).
PRODUCTION OF PERIOSTIN IN SINONASAL
TISSUES
Periostin-positive staining was observed in the base-
ment membrane, extracellular matrix, nasal polyp tis-
sue, and infiltrating cells by means of immunohisto-
chemical staining (Fig. 2A-E). Production of periostin
protein was significantly greater in tissues from pa-
tients with allergic rhinitis (mean = 14.8), chronic rhi-
nosinusitis with nasal polyps (mean = 32.4), or
aspirin-induced asthma patients (mean = 32.5) than in
control tissues (mean = 5.1) (P < 0.05) (Fig. 2A-E).
Patients with chronic rhinosinusitis or aspirin-
induced asthma had significantly stronger protein
production in their nasal polyps than did patients with
allergic rhinitis (Fig. 2F).
EXPRESSION OF PENDRIN AND PERIOSTIN
mRNAs IN SINONASAL TISSUES
Expression of the mRNAs of pendrin was signifi-
cantly greater in the tissues of patients with allergic
rhinitis (mean = 751) or chronic rhinosinusitis with
nasal polyps (mean = 707) than in control tissues
(mean = 53.6) (P < 0.05) (Fig. 3A). Expression of the
mRNAs of periostin was significantly greater in the
tissues of patients with allergic rhinitis (mean = 117)
or chronic rhinosinusitis with nasal polyps (mean =
1500) than in control tissues (mean = 39.7) (P < 0.05)
(Fig. 3B). Patients with chronic rhinosinusitis with
Ishida A et al.
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Fig.　1　Immunohistochemical staining of pendrin in the nasal mucosa (black; arrow) of controls (A) and patients with al-
lergic rhinitis (B), chronic rhinosinusitis with nasal polyps (C), and aspirin-induced asthma (D) (original magnifi cation: 
×100). Pendrin staining is more intense for allergic rhinitis, chronic rhinosinusitis with nasal polyps, and aspirin-induced 
asthma compared with controls. Results are expressed as mean ± SD (n = 10 each group) (E). *P < 0.05 vs. control.
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Fig.　2　Immunohistochemical staining of periostin in nasal mucosa (black; arrow) of control (A), allergic rhinitis (B), 
chronic rhinosinusitis with nasal polyps (C), high power fi eld image of periostin positive infi ltrating cells in chronic rhinosi-
nusitis with nasal polyps (D) and aspirin-induced asthma (E)  (original magnifi cation ×100, high power fi eld ×400). Peri-
ostin staining is more intense in allergic rhinitis, chronic rhinosinusitis with nasal polyps, and aspirin-induced asthma than 
in the control. Results are shown as means ± SD (n = 10 each group)  (F). *P < 0.05 vs. control; #P < 0.05 vs. allergic 
rhinitis.
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Fig.　3　Quantitative RT-PCR analysis of pendrin (A) and periostin (B) mRNA in sinonasal mucosal tissue from 
controls and patients with allergic rhinitis, chronic rhinosinusitis, or aspirin-induced asthma. All mRNA levels are 
expressed as copies per 1000 copies of ACTB, the β-actin housekeeping gene. Results are shown as mean ± 
SD. * P < 0.05 vs. control; #P < 0.05 vs. allergic rhinitis.
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Fig.　4　Western blotting quantifi cation of periostin in sinonasal mucosal tissue from controls and patients with allergic 
rhinitis, chronic rhinosinusitis, or aspirin-induced asthma. Supernatants from fi broblasts stimulated with IL-13 were used 
as positive controls. Results are expressed as mean ± SD (n = 10 each group).
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nasal polyps had significantly stronger periostin
mRNA expression in their sinonasal tissues than did
patients with allergic rhinitis (P < 0.05).
PRODUCTION OF PERIOSTIN PROTEIN IN SI-
NONASAL TISSUES
Production of periostin protein was significantly
greater in the tissues of patients with chronic rhinosi-
nusitis with nasal polyps (mean = 2.42) than in the tis-
sues of controls (mean = 0.40) or patients with aller-
gic rhinitis (mean = 1.23) (P < 0.05) (Fig. 4).
DISCUSSION
Although pendrin and periostin have been implicated
in various immunological events,1-8 their physiologic
functions and potential roles in pathologic conditions
remain to be defined. Here we reveal for the first time
that pendrin and periostin expression is increased in
the sinonasal tissue of patients with allergic rhinitis,
chronic rhinosinusitis with nasal polyps, and aspirin-
induced asthma. Moreover, patients with chronic rhi-
nosinusitis with nasal polyps had higher levels of pen-
drin and periostin production. In sinonasal tissue,
Ishida A et al.
594 Allergology International Vol 61, No4, 2012 www.jsaweb.jp
pendrin production was observed in epithelial cells
and submucosal gland cells,4,6 while periostin produc-
tion was observed in basement membrane cells and
infiltrating cells. Periostin was also expressed in nasal
polyps of patient with chronic rhinosinusitis and in
those with aspirin-induced asthma.
Chronic rhinosinusitis is one of the most fre-
quently encountered chronic nasal diseases, and the
complexity of this condition in the presence of nasal
polyps complicates the study of its etiological thera-
peutics.10-12 Patients with chronic rhinosinusitis
whose symptoms are refractory to treatment often de-
velop nasal polyps. Growth of these polyps leads to
obstruction of the sinonasal passages, and surgery
may be necessary in advanced cases to remove the
polyps to restore sinus ventilation. Proliferation and
thickening of the mucosal epithelium, with focal
squamous metaplasia, glandular hyperplasia, subepi-
thelial fibrosis, and stromal edema with numerous
blood vessels, have been histologically observed in
nasal polyps.10 One of the most important characteris-
tics of chronic rhinosinusitis is the prolonged and ex-
aggerated inflammatory reaction in the paranasal mu-
cous membranes.
Samter’s triad is a condition diagnosed with
aspirin-induced asthma in a subset of patients with
chronic rhinosinusitis with nasal polyps, and it is
characterized by nasal polyps, asthma, and aspirin in-
tolerance.5,13-17 In individuals with aspirin-induced
asthma, nonsteroidal anti-inflammatory agents, in-
cluding aspirin, lead to immediate and severe bron-
chospasm which requires urgent emergency treat-
ment.16 It is hypothesized that a common stimulus
causes inflammation of both the sinonasal and the
bronchopulmonary mucosa.
Allergic rhinitis is a Th2-mediated inflammatory
disease characterized by mucosal eosinophilia, air-
way hyperresponsiveness, and mucus overproduc-
tion.10,12 With subsequent progression of allergic
rhinitis, the airway undergoes structural and pheno-
typic changes resulting in airway remodeling, includ-
ing damage to epithelial cells, goblet cell metaplasia,
subepithelial fibrosis, and smooth muscle hyperplasia
and hypertrophy.11
Pendrin is an anion transporter that plays an impor-
tant role in mucus production.5 Mucus overproduc-
tion is a prominent feature of both bronchial asthma
and chronic obstructive pulmonary disease and is a
major determinant of morbidity and mortality in these
diseases.7 In both asthma and chronic obstructive
pulmonary disease, pendrin is upregulated in airway
epithelial cells in association with mucus overproduc-
tion.7 Our findings show that pendrin was also over-
expressed in the sinonasal tissue, including epithelial
cells and submucosal gland cells, of patients with al-
lergic rhinitis, chronic rhinosinusitis with nasal pol-
yps, and aspirin-induced asthma. The precise mecha-
nism of mucus overproduction under these condi-
tions remains poorly understood, but it is reported
that pendrin induces the production of several inflam-
matory mediators, including TGF-alpha, EGF, and
TNF-alpha, which regulate transcription of the
MUC5AC gene via the activation of transcription fac-
tors.6,7,14 Mucus production may be induced by not
only the direct effect of pendrin on airway epithelial
cells, but also the indirect effect of pendrin through
recruitment of inflammatory cells, particularly neutro-
phils.6
Periostin is a 90-kDa member of the fasciclin-
containing family; it functions as part of the extracel-
lular matrix and its production by airway epithelial
cells is induced by IL-4 and IL-13.3 Periostin is se-
creted by fibroblasts and has a cysteine-rich domain
at its N-terminal end, four tandem fasciclin I domains,
and an alternatively spliced domain at its C-terminal
end.3 Periostin is upregulated in the airway epithelia
of patients with bronchial asthma and is considered
to contribute to remodeling under this condition.3 Pe-
riostin regulates goblet cell metaplasia and mucus
production in airway inflammation, including in bron-
chial asthma.17 Our findings suggest that periostin
plays an important remodeling role in allergic rhinitis
and a polyp formation role in chronic sinusitis and
aspirin-induced asthma.
The upregulation of pendrin and periostin in aller-
gic rhinitis, chronic rhinosinusitis with nasal polyps,
and aspirin-induced asthma suggests pathogenic me-
diation by these proteins. Consequently, pendrin and
periostin may be therapeutic target candidates for
these diseases.
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